Thrombosis and Bleeding Complications in Pediatric Patients with Ventricular Assist Devices

2013 ◽  
Vol 32 (4) ◽  
pp. S290
Author(s):  
J. Conway ◽  
C. Manlhiot ◽  
A.I. Dipchand ◽  
B. McCrindle ◽  
T. Humpl
Keyword(s):  
Pediatric Patients ◽  
Ventricular Assist Devices ◽  
Bleeding Complications ◽  
Ventricular Assist ◽  
Assist Devices

Ventricular Assist Devices as a Bridge to Heart Transplantation or as Destination Therapy in Pediatric Patients

2012 ◽  
Vol 44 (7) ◽  
pp. 2007-2012 ◽  
Author(s):  
G. Brancaccio ◽  
S. Filippelli ◽  
G. Michielon ◽  
R. Iacobelli ◽  
S. Alfieri ◽  
...  
Keyword(s):  
Heart Transplantation ◽  
Pediatric Patients ◽  
Ventricular Assist Devices ◽  
Destination Therapy ◽  
Ventricular Assist ◽  
Assist Devices

scholarly journals An introduction to point-of-care testing in extracorporeal circulation and LVADs

Hematology ◽  
2018 ◽  
Vol 2018 (1) ◽  
pp. 516-521 ◽  
Author(s):  
Rachel Sara Bercovitz
Keyword(s):  
Whole Blood ◽  
Point Of Care ◽  
Blood Platelet ◽  
Ventricular Assist Devices ◽  
Bleeding Complications ◽  
Future Research ◽  
Ventricular Assist ◽  
Assist Devices ◽  
Platelet Aggregometry ◽  
Coagulation Tests

Abstract There is a delicate balance between bleeding and clotting in patients on circuits such as ventricular assist devices or extracorporeal membrane oxygenation. Traditional coagulation tests, prothrombin time, activated partial thromboplastin time, and anti-factor Xa levels, are used to monitor patients on these devices. However, turnaround times and inability to assess global hemostasis, including platelets and fibrinogen have contributed to a recognition that faster, accurate, and more informative coagulation tests are needed. Activated clotting time is used to monitor heparin in patients on circuits and has the advantages of being a near-patient point-of-care test. However, its utility is limited to heparin monitoring. Viscoelastic tests (thromboelastometry and thromboelastography) are global, whole-blood coagulation tests, and whole-blood platelet aggregometry evaluates platelet function. Ideally, these tests can ensure that patients are within the therapeutic range of their antithrombotic medications, identify patients at risk for hemorrhagic or thrombotic complications, and guide management of acute bleeding complications. This ideal is currently hampered by a lack of studies that delineate clear ranges that are clinically relevant. Future research is needed to better understand the optimal use of point-of-care coagulation testing in patients on extracorporeal circuits and ventricular assist devices.

Echocardiographic Evaluation of Ventricular Assist Devices in Pediatric Patients

2013 ◽  
Vol 26 (1) ◽  
pp. 41-49 ◽  
Author(s):  
Ritu Sachdeva ◽  
Elizabeth A. Frazier ◽  
Robert D.B. Jaquiss ◽  
Michiaki Imamura ◽  
Christopher J. Swearingen ◽  
...  
Keyword(s):  
Pediatric Patients ◽  
Ventricular Assist Devices ◽  
Ventricular Assist ◽  
Assist Devices ◽  
Echocardiographic Evaluation
Sign in / Sign up

Export Citation Format

Share Document